FDA Warning Letter — Bridge Exxon

Case 622114 — FEI 3023829480

The FDA took a Warning Letter action against Bridge Exxon on Nov 30, 2021 (Point Pleasant Boro, NJ). The action was issued by CTP and concerns tobacco products.

Action details

Facility
Bridge Exxon
Date
Nov 30, 2021
Fiscal Year
2022
Product Type
Tobacco
Center
CTP
Location
Point Pleasant Boro, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.